2SEVENTY BIO INC's ticker is and the CUSIP is 901384107. A total of 130 filers reported holding 2SEVENTY BIO INC in Q2 2022. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,790,302 | -61.3% | 2,497,526 | 0.0% | 0.06% | -61.6% |
| Q2 2023 | $25,274,963 | -0.8% | 2,497,526 | 0.0% | 0.15% | +5.0% |
| Q1 2023 | $25,474,765 | +31.8% | 2,497,526 | +21.1% | 0.14% | +19.8% |
| Q4 2022 | $19,327,911 | -35.6% | 2,062,744 | 0.0% | 0.12% | -41.1% |
| Q3 2022 | $30,013,000 | +10.2% | 2,062,744 | 0.0% | 0.20% | +27.9% |
| Q2 2022 | $27,228,000 | -22.6% | 2,062,744 | 0.0% | 0.15% | -23.8% |
| Q1 2022 | $35,190,000 | +64.8% | 2,062,744 | +147.6% | 0.20% | +94.2% |
| Q4 2021 | $21,356,000 | – | 833,236 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 5,953,825 | $23,338,994 | 3.82% |
| Newtyn Management, LLC | 3,076,490 | $12,059,841 | 2.98% |
| DAFNA Capital Management LLC | 1,447,465 | $5,674,063 | 1.76% |
| CHI Advisors LLC | 1,002,007 | $3,927,867 | 1.56% |
| AlphaCentric Advisors LLC | 657,500 | $2,577,400 | 1.46% |
| Casdin Capital, LLC | 2,023,913 | $7,933,739 | 0.88% |
| Madison Avenue Partners, LP | 1,494,125 | $5,856,970 | 0.83% |
| Bain Capital Life Sciences Investors, LLC | 1,408,901 | $5,522,892 | 0.62% |
| Eversept Partners, LP | 1,453,378 | $5,697,242 | 0.48% |
| Engine Capital Management, LP | 341,870 | $1,340,130 | 0.30% |